Abstract

We evaluated serum total bilirubin levels as a predictor for metabolic syndrome (MetS) and investigated the relationship between serum total bilirubin levels and MetS prevalence. This cross-sectional study included 1728 participants over 65 years of age from Eastern China. Anthropometric data, lifestyle information, and previous medical history were collected. We then measured serum levels of fasting blood-glucose, total cholesterol, triglycerides, and total bilirubin, as well as alanine aminotransferase activity. The prevalence of MetS and each of its individual component were calculated per quartile of total bilirubin level. Logistic regression was used to assess the correlation between serum total bilirubin levels and MetS. Total bilirubin level in the women who did not have MetS was significantly higher than in those who had MetS (P<0.001). Serum total bilirubin quartiles were linearly and negatively correlated with MetS prevalence and hypertriglyceridemia (HTG) in females (P<0.005). Logistic regression showed that serum total bilirubin was an independent predictor of MetS for females (OR: 0.910, 95%CI: 0.863–0.960; P=0.001). The present study suggests that physiological levels of serum total bilirubin might be an independent risk factor for aged Chinese women, and the prevalence of MetS and HTG are negatively correlated to serum total bilirubin levels.

Highlights

  • Metabolic syndrome (MetS) is a group of common, complex disorders including insulin resistance, hypertension, dyslipidemia, and obesity [1]

  • Weight, height, blood pressure, TG, total cholesterol (TC), ALT and total bilirubin (TBIL) were significantly different between the two genders (Po0.05)

  • We found that total bilirubin (OR: 0.952, 95%CI: 0.915–0.990; P=0.014) and ALT (OR: 1.048, 95%CI: 1.038–1.058; Po0.001) were independent predictors of MetS

Read more

Summary

Introduction

Metabolic syndrome (MetS) is a group of common, complex disorders including insulin resistance, hypertension, dyslipidemia, and obesity (especially abdominal obesity) [1]. It is strongly associated with cardiovascular disease. Other studies have shown that the serum bilirubin level can be used as an early biomarker for the progression to MetS in asymptomatic patients [15]. Together, these findings suggest that bilirubin plays a role in the development of MetS

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call